ストックスクリーナーアプリを入手
0.2705
1.05%
0.0028
前日終値:
$0.2677
開ける：
$0.285
24時間の取引高:
80,723
Relative Volume:
0.45
時価総額：
$2.71M
収益：
$6.98M
当期純損益:
$-12.70M
株価収益率:
-0.0254
EPS:
-10.64
ネットキャッシュフロー:
$-6.94M
1週間 パフォーマンス:
+9.38%
1か月 パフォーマンス:
-33.65%
6か月 パフォーマンス:
-55.66%
1年 パフォーマンス:
-78.70%
1日の値動き範囲:
$0.27
$0.285
1週間の範囲:
$0.232
$0.2919
52週間の値動き範囲:
$0.2208
$2.27
Petros Pharmaceuticals Inc Stock (PTPI) Company Profile
名前
Petros Pharmaceuticals Inc
セクター
電話
973-242-0005
住所
1185 AVENUE OF THE AMERICAS, 3RD FLOOR, NEW YORK
PTPI を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
PTPI
Petros Pharmaceuticals Inc
|
0.2705 | 2.71M | 6.98M | -12.70M | -6.94M | -10.64 |
|
ZTS
Zoetis Inc
|
176.74 | 80.59B | 9.15B | 2.43B | 2.31B | 4.92 |
|
HLN
Haleon Plc Adr
|
9.72 | 44.17B | 14.26B | 1.55B | 0 | 0.3327 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.57 | 42.61B | 30.27B | 1.93B | 3.45B | 0.444 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.57 | 18.77B | 16.77B | -959.00M | 1.37B | -2.00 |
|
VTRS
Viatris Inc
|
13.22 | 15.73B | 15.05B | -883.30M | 1.89B | 1.53 |
Petros Pharmaceuticals Inc (PTPI) 最新ニュース
Petros Pharmaceuticals announces shareholder meeting outcomes - Investing.com
Petros Pharmaceuticals Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance
Petros Pharmaceuticals, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Petros Pharmaceuticals stock hits 52-week low at $0.28 - Investing.com
Petros Pharmaceuticals stock hits 52-week low at $0.28 By Investing.com - Investing.com Canada
It's Probably Less Likely That Petros Pharmaceuticals, Inc.'s (NASDAQ:PTPI) CEO Will See A Huge Pay Rise This Year - Simply Wall St
Bragg Gaming Group (OTCMKTS:BRGGD) Shares Down 2.2% – What’s Next? - Defense World
Short Interest in Zions Bancorporation N.A. – 6.9 (NASDAQ:ZIONL) Increases By 170.0% - Defense World
Petros Pharmaceuticals Amends President’s Employment Terms - Yahoo Finance
Petros Pharmaceuticals adjusts executive's salary and terms - Investing.com India
Petros Pharmaceuticals adjusts executive's salary and terms By Investing.com - Investing.com South Africa
Petros Pharmaceuticals amends preferred stock terms - Investing.com India
Petros Pharmaceuticals amends preferred stock terms By Investing.com - Investing.com UK
Petros Pharmaceuticals sees two board members resign By Investing.com - Investing.com Australia
Petros Pharmaceuticals sees two board members resign - Investing.com India
Board Reshuffle at Petros Pharmaceuticals Following Resignations - TipRanks
Petros Pharmaceuticals, Inc. Announces Board Resignations - Marketscreener.com
Otsuka and Lundbeck Announce Barbara Corcoran Led Campaign to Raise Awareness of Alzheimer’s Dementia - Pharmaceutical Executive
Petros Pharmaceuticals sets date for 2024 annual meeting - Investing.com
Petros Pharmaceuticals reports high comprehension in drug app study - Investing.com
Petros Pharmaceuticals Executes Successful Initial Test for App Comprehension as Part of FDA Pathway for Over-the-Counter Access for STENDRA(R) (avanafil) - AccessWire
Petros Pharmaceuticals to Present at the H.C. Wainwright 26th Annual Global Investment Conference - AccessWire
A History of Outperforming Analyst Forecasts and Beating the Odds: Petros Pharmaceuticals Inc (PTPI) - SETE News
Analytical Overview: Petros Pharmaceuticals Inc (PTPI)’s Ratios Tell a Financial Story - The Dwinnex
A stock that deserves closer examination: Petros Pharmaceuticals Inc (PTPI) - US Post News
Petros Pharmaceuticals Second Quarter 2024 Earnings: Beats Expectations - Yahoo Finance
PTPI Stock Earnings: Petros Pharmaceuticals Beats EPS, Beats Revenue for Q2 2024 - MSN
Petros Pharmaceuticals (NASDAQ:PTPI) Stock Price Down 10.4% - Defense World
Petros Pharmaceuticals stock hits 52-week low at $0.37 - Investing.com
Joel Baglole - InvestorPlace
Closing Figures: Petros Pharmaceuticals Inc (PTPI)’s Negative Finish at 0.41, Down -3.55 - The Dwinnex
Petros Pharmaceuticals reports promising Web App study - Investing.com
PTPI’s Market Whiplash: -70.74% YTD Decline, -7.41% Plunge in 30 Days - The InvestChronicle
Petros Pharmaceuticals Inc (NASDAQ:PTPI) stock: Is this a flash in the pan today? - US Post News
Petros Pharmaceuticals' Pivotal Statistically Significant Self Selection Study Shows Stronger Results with Proprietary Technology Application as Part of FDA Pathway for Over-the-Counter Access for STENDRA(R) (avanafil) - AccessWire
Petros Pharma (NASDAQ:PTPI) Stock Quotes, Forecast and News Summary - Benzinga
Get in on Petros Pharmaceuticals Inc’s (PTPI) buy-in window today! - SETE News
Financial Metrics Exploration: Understanding Petros Pharmaceuticals Inc (PTPI) Through Ratios - The Dwinnex
Petros reports successful study for STENDRA OTC switch By Investing.com - Investing.com Canada
Petros Pharmaceuticals Inc Inc. (PTPI) Price Performance: A Technical Analysis Perspective - The InvestChronicle
Petros reports successful study for STENDRA OTC switch - Investing.com
Petros Pharmaceuticals’ STENDRA(R) (avanafil) Pivotal Consumer Self-Selection Study for Over-the-Counter Access Demonstrates Statistical Significance - AccessWire
Quarterly Metrics: Quick and Current Ratios for Petros Pharmaceuticals Inc (PTPI) – DWinneX - The Dwinnex
Can you still get a good price for Petros Pharmaceuticals Inc (PTPI) Shares at this point? - US Post News
Pioneering change: male contraceptives and the coming OTC revolution - Interesting Engineering
The future of health: male contraceptives and OTC innovation - Interesting Engineering
Petros Pharmaceuticals Inc (PTPI) 財務データ
収益
当期純利益
現金流量
EPS
0.83%
1.03%
大文字化:
|
ボリューム (24 時間):